Genmab | GEN - 貿易債権者

株価
1,669.50
毎日の変更
14.50 0.88%
毎月
-2.54%
毎年
19.34%
Q2 予測
1,628.53




貿易債権者 変化する 日付
Agios Pharmaceuticals USD 13.75M 4.61M 2026-03
Almirall EUR 258.05M 58.66M 2025-12
Amarin USD 48.15M 2.8M 2026-03
Amgen USD 20.89B 1.25B 2025-12
argenx SE USD 852.2M 369.5M 2025-06
AstraZeneca USD 22.51B 2.78B 2026-03
Bayer EUR 7.08B 700M 2025-12
BioMarin Pharmaceutical USD 759.03M 39.41M 2025-12
Demant DKK 923M 41M 2025-12
Exelixis USD 29.62M 4.27M 2025-12
Fresenius Medical Care EUR 835.55M 109.7M 2025-12
Galapagos EUR 104.65M 4.02M 2025-12
Genmab DKK 6M 2M 2025-09
GlaxoSmithKline GBP 14.34B 1.05B 2026-03
GN Store Nord DKK 1.5B 101M 2025-12
GRIFOLS EUR 841M 37.68M 2025-12
Hikma Pharmaceutical USD 715M 104M 2025-12
Insmed USD 79.91M 316K 2025-12
Lonza CHF 471M 3M 2024-12
Merck EUR 2.11B 182M 2025-12
Novartis USD 4.46B 99M 2025-12
Regeneron Pharmaceuticals USD 1.03B 4.81B 2026-03
Roche Holding CHF 5.78B 1.27B 2025-12
Sanofi EUR 22.71B 219M 2026-03
UCB EUR 4.04B 755M 2025-12